sAmai7DU

SANDU PHARMACEUTICALS LTD.

Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa-403511.
/ 6715000, Fax: +91 832 2407008, E-mail: sandupharma@sandu.in

Ref: SPL/CORP-SEC/2016-17/BSE/311

Dated: 14th February 2017

TO,
Bombay Stock Exchange Ltd,
Phiroj shah Jeejobhoy Towers,
25th Floor, Dalal Street,
Mumbai 400 001
Manager-Department of Corporate affairs
Sir'
Sub: Outcome of the 6th Board Meeting held on Tuesday, 14th
February 2017 with Scrip Code 524703

A Meeting of the Board of Directors of the Company duly convened on

Tuesday,14th February 2017 at 5.00 p.in. at the Corporate Office of the
Company at Sandu Nagar , D K Sandu Marg, Chembur, Mumbai inter alia,
discussed the following business:-

1. It has approved Un Audited Financial Results for Quarter ended 31St

December 2016 along with Limited Review Report.
2. It has approved Re-appointment of M/s N. J. Prabhudesai & Associates,
Chartered Accountant, Panaji Goa to undertake Internal Audit of the
plant operations at Pileme, Goa and M/s Lalit Gawde & Associates,
Chartered Accountant, Mumbai engaged with M/s Sandu
Pharmaceuticals Limited from past several years for conducting Internal
Audit of the functio-ns and activities of the company for the Financial
Year 2017-2018.
3. It has taken on record the familarisation programme imparted to
Independent Director for the Financial Year ended 2016-17.
4. It has taken on record the performance evaluation done by Independent
Directors at the Independent Director Meeting dated 14th February 2017.
5. It has evaluated the performance of Independent Director
6. It has considered and authorized deletion of Shri Nikesh Shah nalne as
Chief Financial Officer/Key Managerial Personnel from companies record

AN ISO 9001 :2008 CERTIF.ED 0RGANISATloN

Corporate Office: P. 8. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai -400 071.
Tel: +91 22 25284402/3306, Fax: +91 22 25282403, E-mail: info@sandu.in, Web: www.sandu.in
sAfidr SANDU PHARMACEUTICALS LTD.
Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa-403511.
Tel: +91 832 2407474 / 6715000, Fax: +91 832 2407008, E-mail: sandupharma@sandu.in

/various documents mentioning his name filed /submitted with

BSE/ASEL and other authorities pursuant to his resignation.

The Statutory Auditor of the Company has carried out Limited Review of the
said results, the copy of which is enclosed herewith.

The Board Meeting Commenced at 5.00 pin and Concluded at 6.30 p.in.

Thanking You,

Yours faithfully,

For Sandu Pharmaceuticals Limited

g A

Pratika Shenvi Dessai

Company Secretary

AN ISO 9001 :2008 CERTIFIED ORGANISAT.ON

Corporate Office: P. 8. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai -400 071.
i I- "iiH Tel: +91 22 25284402/3306, Fax: +91 22 25282403, E-mail: info@sandu.in, Web: www.sandu.in
 Diteep &,Pritftvi
CHARTERED ACCOUNTANTS

FINANCIAL RESULTS
INDEPENDENT AUDITORS' REVIEW REPORT ON REVIEW OF INTREM

To,
The Board of Directors,
Sandu Pharmaceuticals Limited
PlotNo.25,26,29 &30,
Pilerne Industrial Estate, Marra,
Bardez, Goa-403511.

Dear Sirs,

WehavereviewedtheaccompanyingstatementofunauditedfinancialresultsofSandu
pharmaceuticals Limited ("the Comp"nyf for the quarter and nine month ended 31't December'
2016 ('the Statement"), being t"t-itt"O by the company pursuant to the
requirement of
Regulation, 2015'
Regulation 33 of the SEiiI (Lisiing Obligation and Disclosure Requirements)

and approved by the

This statement which is the responsibility of the Company's Management
recognition measurement principles
Board of Directors, has been prepared in accordance with
and
ulder- section 133 of
laid down in Accounting Standard for Interim Reporting (AS 25), prescribe
other
the companies Act, Zdl:, read with relevant rules issued thereunder and
accounting
on these financial
principles generally accepted in India. Our responsibility is to issue a report
statements based on our review.

we conducted our review in accordance with the standard on Review Engagement (SRE) 2410,
,,Review of Interirri Financial Information Performed by t!9 Independent Auditor. of the Entity"'
standard requires that we plan and
issued uy irre Institute of charteied Accountants of India. This
are free of
performihe review to obtain moderate assurance as to whether the financial statements
material misstatement. A review is limited primarily to inquiries of
company personnel and
than an audit' We
analytical procedure applied to financial data and thus provides less assurance
an audit opinion'
have not performed arraudit and accordingly, we do not express

Based on our review conducted as above, nothing has come

to our attention that causes us to
results prepared in accordance
believe that the accompanyrng statement of unaudited financial
practices and policit:3:
with applicable accouniing staidards and other recognised accounting
Regulation 33 of the sEBI
not disclosed the informaiion required to be disclosed in terms of
including the manner in
(Listing Obligations and Disclosure Requirements) Regulations, 2Ol5
which it is to be disclosed, or that it contains any material misstatement'

For Dileep & Prithvi

Chartered Accountants
Firm Reg. No, 122290W

Pankaj Jain
(Partner)
M. No.: 139559
Place: Mumbai
Date : l4th Febru dtY, 2Ol7

4-4, 3rd Floor, Dahanukar Bldg., 480, Kalbadevi Road, Mumbai - 400 002.
Tel. : +91 -22-2207 1184 I 85 I 2207 1102 . E-mail cad i leepp rithva@g m a i I co m
: .